The results showed that blockade of HMGB1 signaling diminished the antitumor effect of β-lap (Fig. 4g), indicating that β-lap may induce HMGB1 release in the tumor microenvironment to enhance innate response via a TLR4/MyD88 pathway. The gene discussed is HMGB1; the disease is neoplasm.